According to IMARC Group’s latest report, titled “Oligonucleotide Synthesis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, The global oligonucleotide synthesis market exhibited strong growth during 2015-2020. Oligonucleotide synthesis is the chemical synthesis of little fragments of nucleic acids that are produced through enzymatic chemistry and genetic engineering. It is used in laboratories for diagnostics, academic, industrial, and therapeutic applications. Oligonucleotide synthesis helps in building monoclonal antibody primers and probes in recombinant deoxyribonucleic acid (DNA) technologies. It is majorly utilized in medical, biological, forensic, and clinical applications for gene cloning, expression, molecular diagnostics and genetic disease screening.
Request for a PDF
sample of this report: https://www.imarcgroup.com/oligonucleotide-synthesis-market/requestsample
The rapid spread of coronavirus
disease (COVID-19) has led to the emergent need for a potential treatment,
including DNA and Ribonucleic acid (RNA) vaccines. This represents one of the
primary factors driving the global oligonucleotide synthesis market toward
growth. In line with this, an increasing focus on providing personalized medical
care is contributing to the market growth. The rising prevalence of cancer and
other chronic illnesses has positively influenced the demand for novel
diagnostics, which is acting as another major growth-inducing factor. Increasing
investments by governments of various nations in the research and development
(R&D) of advanced genomic technologies are further creating a positive
outlook for the market. Looking forward, IMARC Group expects the global
oligonucleotide synthesis market to grow at a CAGR of around 14% during the
forecast period (2021-2026).
As the novel
coronavirus (COVID-19) crisis takes over the world, we are continuously
tracking the changes in the markets, as well as the industry behaviors of the
consumers globally and our estimates about the latest market trends and
forecasts are being done after considering the impact of this pandemic.
Competitive Landscape with Key Players:
·
Agilent Technologies Inc.
·
Biolegio B.V.
·
Bio-Synthesis Inc
·
Eurofins Genomics
·
GenScript
·
Horizon Discovery Ltd
·
Integrated DNA Technologies Inc (Danaher Corporation)
·
Kaneka Eurogentec S.A. (Kaneka Corporation)
·
LGC Limited
·
Nitto Denko Avecia Inc (Nitto Denko Corporation)
·
Thermo Fisher Scientific Inc.
Market
Segmentation:
Breakup by Product:
·
Synthesized Oligonucleotide
Products
·
Reagents
·
Equipment
·
Services
Breakup by Application:
·
PCR Primers
·
PCR Assays and Panels
·
Sequencing
·
DNA Microarrays
·
Fluorescence In-Situ
Hybridization (FISH)
·
Antisense Oligonucleotides
·
Others
Breakup by End Use:
·
Pharmaceutical and
Biotechnology Companies
·
Hospital and Diagnostic Laboratories
·
Academic Research
Institutes
·
North America (United
States, Canada)
·
Europe (Germany, France,
United Kingdom, Italy, Spain, Others)
·
Asia Pacific (China, Japan,
India, Australia, Indonesia, Korea, Others)
·
Latin America (Brazil,
Mexico, Others)
·
Middle East and Africa
(United Arab Emirates, Saudi Arabia, Qatar, Iraq, Others)
Ask Analyst for Customization and
Explore full report with TOC & List of Figures: https://www.imarcgroup.com/oligonucleotide-synthesis-market
We are updating our reports, If you
want latest primary and secondary data (2021-2026) with Cost Module, Business
Strategy, Distribution Channel, etc. Click request free sample report,
published report will be delivered to you in PDF format via email within 24 to
48 hours.
Key highlights of the report:
- Market Performance (2015-2020)
- Market Outlook (2021-2026)
- Market Trends
- Market Drivers and Success Factors
- The Impact of COVID-19 on the Global Market
- Value Chain Analysis
- Structure of the Global Market
- Comprehensive mapping of the competitive landscape
If
you need specific information that is not currently within the scope of the
report, we will provide it to you as a part of the customization.
Related Reports by IMARC Group:
Bioinformatics Market: https://www.imarcgroup.com/bioinformatics-market
Oncology Active Pharmaceutical Ingredients
Market: https://www.imarcgroup.com/oncology-active-pharmaceutical-ingredients-market
Surgical Microscopes Market: https://www.imarcgroup.com/surgical-microscopes-market
Defibrillators Market: https://www.imarcgroup.com/defibrillators-market
Digital Health Market: https://www.imarcgroup.com/digital-health-market
Pharmacy Automation Market: https://www.imarcgroup.com/pharmacy-automation-market
Cell Analysis Market: https://www.imarcgroup.com/cell-analysis-market
Organic and Natural Pet Food Market: https://www.imarcgroup.com/organic-natural-pet-food-market
Angioplasty Balloons Market: https://www.imarcgroup.com/angioplasty-balloons-market
Minimally Invasive Surgery Market: https://www.imarcgroup.com/minimally-invasive-surgery-market
Dental Implants Market: https://www.imarcgroup.com/dental-implants-market
Healthcare It Market: https://www.imarcgroup.com/healthcare-it-market
IMARC’s information
products include major market, scientific, economic and technological
developments for business leaders in pharmaceutical, industrial, and high
technology organizations. Market forecasts and industry analysis for
biotechnology, advanced materials, pharmaceuticals, food and beverage, travel
and tourism, nanotechnology and novel processing methods are at the top of the
company’s expertise.
IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA - Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas: - +1 631 791 1145 | Africa
and Europe: - +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
No comments:
Post a Comment